New transplant strategy shows promise for lymphoma patients
NCT ID NCT01208896
First seen May 13, 2026 · Last updated May 24, 2026 · Updated 3 times
Summary
This study tested a stem cell transplant approach for people with follicular lymphoma that had returned after previous treatments. The goal was to see if adding a drug called Rituximab to the transplant process could help control the disease and reduce side effects. The study included 32 adults aged 18 to 65 who had already tried other treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA, FOLLICULAR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
APHP Hôpital Henri-Mondor
Paris, 94010, France
-
APHP Hôpital Necker-Enfants malades
Paris, 75015, France
-
APHP Hôpital Pitié-Salpêtrière
Paris, 75651, France
-
APHP Hôpital Saint Louis
Paris, 75475, France
-
CHRU Lille
Lille, 59037, France
-
CHRU Tours
Tours, 37000, France
-
CHU Grenoble
Grenoble, 38043, France
-
CHU Limoges
Limoges, 87042, France
-
CHU Nancy
Nancy, 54511, France
-
CHU Poitiers - La Milétrie
Poitiers, 86000, France
-
Centre Henri Becquerel
Rouen, France
-
Département d'Hématologie et d'Oncologie, Hôpital CHRU de Hautepierre
Strasbourg, 67098, France
-
Hôpital Edouard Herriot
Lyon, 69374, France
-
Institut Gustave Roussy
Villejuif, 94805, France
-
Institut de Cancérologie de la Loire
Saint-Etienne, 60008, France
-
Service Hématologie Clinique, CHU -Hôtel Dieu
Nantes, 44093, France
-
Service Hématologie Clinique, Hôpital Archet 1
Nice, 06202, France
-
Service Hématologie Clinique, Hôpital Pontchaillou
Rennes, 35033, France
-
Service Hématologie Oncologie, Hôpital Lapeyronie, CHU de Montpellier
Montpellier, 34295, France
-
Service Hématologie et Thérapie cellulaire, Pavillon Villemin Pasteur, CHU Clermont-Ferrand
Clermont-Ferrand, 63000, France
-
Service Hématologie, Hôpital Augustin Morvan
Brest, 29609, France
-
Service Hématologie, Hôpital Minjoz
Besançon, 25030, France
-
Service Hématologie, Hôpital Purpan
Toulouse, 31059, France
-
Service des maladies du sang - Hôpital Haut-Lévêque - avenue de magellan
Pessac, 33600, France
-
University Hospital Angers
Angers, Angers, 49033, France
-
University Hospital, Caen
Caen, France
Conditions
Explore the condition pages connected to this study.